Cargando…

Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival

The optimal time for starting radiation in patients with glioblastoma (GBM) is controversial. We aimed to evaluate postoperative radiotherapy treatment patterns and the impact of timing of radiotherapy on survival outcomes in patients with GBM using a large, national hospital-based registry in the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pollom, Erqi L, Fujimoto, Dylann K, Han, Summer S, Harris, Jeremy P, Tharin, Suzanne A, Soltys, Scott G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Supplement Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868191/ https://www.ncbi.nlm.nih.gov/pubmed/29432548 http://dx.doi.org/10.1093/jrr/rrx103

Ejemplares similares

Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies
por: Myall, Nathaniel J, et al.
Publicado: (2021)

NQPC-08 Short-time intensive rehabilitation for patients with newly diagnosed glioblastoma
por: Matsutani, Masao, et al.
Publicado: (2020)

RADI-12. Deep learning for automatic detection and contouring of metastatic brain tumors in stereotactic radiosurgery: a retrospective analysis with an FDA-cleared software algorithm
por: Wang, Jen-Yeu, et al.
Publicado: (2021)

NEIM-08 A PHASE II STUDY OF MULTIPARAMETRIC MR-GUIDED HIGH DOSE ADAPTIVE RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
por: Kim, Michelle, et al.
Publicado: (2022)

COT-20 Clinical experience with tumor-treating fields therapy for newly diagnosed glioblastoma
por: Saito, Norihiko, et al.
Publicado: (2020)

SYST-11 PHASE 2 STUDY OF VAL-083 AND RADIOTHERAPY IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM
por: Chen, Zhongping, et al.
Publicado: (2022)

Radiotherapy for Newly Diagnosed Glioblastoma in the Elderly: What Is the Standard?
por: Wee, Chan Woo
Publicado: (2022)

ES-2 Phase 3 TRIDENT Trial: Radiation and Temozolomide with or without Tumor Treating Fields in newly diagnosed glioblastoma
por: Nakada, Mitsutoshi
Publicado: (2020)

CLRM-09 FIRST-LINE Tumor TREATING FIELDS (200 KHZ) THERAPY FOR NEWLY-DIAGNOSED GLIOBLASTOMA: THE PHASE 3 TRIDENT TRIAL (EF-32)
por: Shi, Wenyin, et al.
Publicado: (2022)

The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
por: Poulsen, Sidsel Højklint, et al.
Publicado: (2016)

Survival impact of delaying postoperative chemoradiotherapy in newly-diagnosed glioblastoma patients
por: Zhang, Maochen, et al.
Publicado: (2020)

Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma
por: Katsigiannis, Sotirios, et al.
Publicado: (2019)

Avelumab in newly diagnosed glioblastoma
por: Jacques, Francois H, et al.
Publicado: (2021)

Palliative Care Service Utilization and Advance Care Planning for Adult Glioblastoma Patients: A Systematic Review
por: Wu, Adela, et al.
Publicado: (2021)

Clinical impact of the VOLO optimizer on treatment plan quality and clinical treatment efficiency for CyberKnife
por: Schüler, Emil, et al.
Publicado: (2020)

Optimizing linkage to care and initiation and retention on treatment of adolescents with newly diagnosed HIV infection
por: Ruria, Eva Caroline, et al.
Publicado: (2017)

Advances in the treatment of newly diagnosed glioblastoma
por: Theeler, Brett J., et al.
Publicado: (2015)

A Review of Newly Diagnosed Glioblastoma
por: Oronsky, Bryan, et al.
Publicado: (2021)

Newly Diagnosed Glioblastoma in Elderly Patients
por: Yuen, Carlen A., et al.
Publicado: (2022)

Does radiotherapy still have a role in unresected biliary tract cancer?
por: Pollom, Erqi L., et al.
Publicado: (2016)

Diffusion MRI Characteristics After Concurrent Radiochemotherapy Predicts Progression-Free and Overall Survival in Newly Diagnosed Glioblastoma
por: Chang, Warren, et al.
Publicado: (2015)

Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survival
por: Schneider, Matthias, et al.
Publicado: (2020)

Feasibility, Safety and Impact on Overall Survival of Awake Resection for Newly Diagnosed Supratentorial IDH-Wildtype Glioblastomas in Adults
por: Moiraghi, Alessandro, et al.
Publicado: (2021)

1354P Delay of diagnoses, increase of advanced stages, and worse overall survival in patients with thoracic malignancies because of the COVID-19 pandemic
por: Sbrana, A., et al.
Publicado: (2022)

Outcomes in Newly Diagnosed Elderly Glioblastoma Patients after Concomitant Temozolomide Administration and Hypofractionated Radiotherapy
por: Nguyen, Ludovic T., et al.
Publicado: (2013)

Pre-Radiotherapy Progression after Surgery of Newly Diagnosed Glioblastoma: Corroboration of New Prognostic Variable
por: Lakomy, Radek, et al.
Publicado: (2020)

Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial
por: Compter, Inge, et al.
Publicado: (2020)

Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH–Wild-Type Glioblastoma
por: Albert, Nathalie L., et al.
Publicado: (2023)

ML-08 Safety and efficacy of consolidation cytarabine for newly-diagnosed primary central nervous system lymphoma
por: Sasaki, Nobuyoshi, et al.
Publicado: (2020)

Perioperative red blood cell transfusion is associated with poor functional outcome and overall survival in patients with newly diagnosed glioblastoma
por: Schneider, Matthias, et al.
Publicado: (2021)

Correction: Newly Diagnosed Glioblastoma in Elderly Patients
por: Yuen, Carlen A., et al.
Publicado: (2022)

Interstitial photodynamic therapy for newly diagnosed glioblastoma
por: Quach, Stefanie, et al.
Publicado: (2023)

LOCL-16 IMPACT OF MGMT PROMOTER METHYLATION STATUS ON TUMOR DYNAMICS DURING WEEKLY ADAPTIVE RADIOTHERAPY FOR GLIOBLASTOMA
por: Hudson, John M, et al.
Publicado: (2022)

SYST-08. A phase II trial of concurrent Sunitinib, Temozolomide and Radiation Therapy followed by adjuvant Temozolomide for newly diagnosed Glioblastoma patients with an unmethylated MGMT gene promoter (A01-M121-11A, McG1132)
por: Faye, Mame Daro, et al.
Publicado: (2021)

A comparison between oral chemotherapy combined with radiotherapy and radiotherapy for newly diagnosed glioblastoma: A systematic review and meta-analysis
por: Wang, Zhuo, et al.
Publicado: (2017)

ML-16 First clinical experience of administration of Tirabrutinib for the patients with newly diagnosed primary central nervous system lymphoma
por: Onodera, Sho, et al.
Publicado: (2021)

Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas : A Prospective Multicenter Study of Korean Patients
por: Joo, Jin-Deok, et al.
Publicado: (2012)

Prognostic significance of concomitant radiotherapy in newly diagnosed glioblastoma multiforme: a multivariate analysis of 116 patients
por: Okumus, Nilgun Ozbek, et al.
Publicado: (2012)

Hypofractionated radiotherapy for newly diagnosed elderly glioblastoma patients: A systematic review and network meta-analysis
por: de Melo, Suely Maymone, et al.
Publicado: (2021)

Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial
por: Saran, Frank, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qdlpfhphr1accn75e6alri2g7p